Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CODAvision: best practices and a user-friendly interface for rapid, customizable segmentation of medical images.

Nature protocols·2026
Same author

SAMJ: fast image annotation on ImageJ/Fiji via segment anything model.

Nature communications·2026
Same author

Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.

NPJ precision oncology·2026
Same author

Quantitative sleep EEG identifies CSF core biomarker-related subgroups in Alzheimer's disease.

GeroScience·2026
Same author

Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells.

Cell reports methods·2026
Same author

Acidosis Regulates Microtubule Dynamics via the β1 Integrin/RhoA/CRMP-2 Axis.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Jan 16, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

12.0K

Computational Methods for Cancer Neoantigen Prediction.

Andrea Moreno-Manuel1, Sotiris Ouzounis2, Marius Eidsaa3

  • 1Cancer Heterogeneity and Immunomics (CHI) Group, University Hospital Lozano Blesa, Aragon Health Research Institute (IISA), Zaragoza, Spain.

Methods in Molecular Biology (Clifton, N.J.)
|September 30, 2025
PubMed
Summary

Neoantigens, mutated peptides from tumors, are key targets for cancer immunotherapy. Computational tools are advancing to identify and prioritize these neoantigens for personalized treatments.

Keywords:
BioinformaticsCancerHLA-binding affinityImmune microenvironmentImmunomicsMHCMiceNeoantigen prediction

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K

Related Experiment Videos

Last Updated: Jan 16, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

12.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K

Area of Science:

  • Oncology
  • Immunology
  • Bioinformatics

Background:

  • Neoantigens arise from tumor-specific mutations and are recognized by the immune system, driving antitumor responses.
  • The rise of cancer immunotherapies has intensified the focus on neoantigens.
  • Computational tools are crucial for identifying and prioritizing neoantigens for experimental validation.

Purpose of the Study:

  • To detail the in silico identification and prioritization of potential neoantigens.
  • To review and compare current bioinformatics tools and pipelines for neoantigen prediction in humans and mice.
  • To discuss the technical challenges and future improvements in neoantigen prediction, particularly with AI integration.

Main Methods:

  • In silico identification of neoantigens using computational tools.
  • Comparison of leading bioinformatics pipelines for neoantigen prediction.
  • Analysis of artificial intelligence applications in neoantigen discovery.

Main Results:

  • Key steps for in silico neoantigen identification are outlined.
  • A comparison of frequently used and cutting-edge neoantigen prediction tools is provided.
  • Technical limitations and AI-driven advancements in neoantigen prediction are discussed.

Conclusions:

  • Advances in immunomics and computational biology are essential for personalized cancer immunotherapy.
  • Improved neoantigen prediction will enhance the clinical application of immunotherapies.
  • AI integration promises significant improvements in neoantigen discovery and cancer patient outcomes.